Chinese Journal of Antituberculosis ›› 2025, Vol. 47 ›› Issue (8): 1053-1061.doi: 10.19982/j.issn.1000-6621.20250033
• Original Articles • Previous Articles Next Articles
Jiao Jiahuan1,2, Sun Changfeng2,3, Wu Gang2, Huang Fuli2, Sheng Yunjian2()
Received:
2025-01-21
Online:
2025-08-10
Published:
2025-08-01
Contact:
Sheng Yunjian, Email: sheng200410@163.com
Supported by:
CLC Number:
Jiao Jiahuan, Sun Changfeng, Wu Gang, Huang Fuli, Sheng Yunjian. The value of machine learning algorithm-based diagnostic models in tuberculous pleural effusion[J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1053-1061. doi: 10.19982/j.issn.1000-6621.20250033
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250033
资料 | 合计(233例) | 结核组(106例) | 非结核组(127例) | 统计检验值 | P值 | |||||
---|---|---|---|---|---|---|---|---|---|---|
年龄(岁) | 54.71±21.15 | 40.23±20.31 | 66.80±12.48 | t=11.746 | <0.001 | |||||
性别 | χ2=0.280 | 0.596 | ||||||||
男性 | 163(70.0) | 76(71.7) | 87(68.5) | |||||||
女性 | 70(30.0) | 30(28.3) | 40(31.5) | |||||||
发热 | χ2=5.933 | 0.015 | ||||||||
是 | 62(26.6) | 38(35.8) | 24(18.9) | |||||||
否 | 171(73.4) | 68(64.2) | 103(81.1) | |||||||
咳嗽 | χ2=0.048 | 0.825 | ||||||||
是 | 173(74.2) | 83(78.3) | 90(70.9) | |||||||
否 | 60(25.8) | 23(21.7) | 37(29.1) | |||||||
气促 | χ2=0.113 | 0.737 | ||||||||
是 | 130(55.8) | 64(60.4) | 66(52.0) | |||||||
否 | 103(44.2) | 42(39.6) | 61(48.0) | |||||||
盗汗 | χ2=14.823 | <0.001 | ||||||||
是 | 13(5.6) | 13(12.3) | 0(0.0) | |||||||
否 | 220(94.4) | 93(87.7) | 127(100.0) | |||||||
胸腔积液 | ||||||||||
总蛋白(g/L) | 45.56±9.08 | 50.29±5.79 | 41.59±9.45 | t=-8.591 | <0.001 | |||||
腺苷脱氨酶(U/L) | 31.50±24.90 | 46.82±17.87 | 18.61±22.61 | t=-10.397 | <0.001 | |||||
乳酸脱氢酶(U/L) | 796.26±1435.88 | 650.35±1450.27 | 919.01±1417.79 | t=1.420 | 0.157 | |||||
癌抗原125(u/ml) | 391.95(217.03,600.00) | 357.00(139.25,591.88) | 429.50(281.50,600.00) | Z=2.569 | 0.021 | |||||
癌胚抗原(ng/ml) | 1.17(0.50,3.21) | 0.51(0.50,1.21) | 2.37(0.93,90.98) | Z=7.729 | <0.001 | |||||
细胞数(×109/L) | 1.59(0.70,3.24) | 2.19(1.22,3.50) | 0.99(0.47,2.22) | Z=1.582 | <0.001 | |||||
多核比 | 0.11(0.05,0.42) | 0.06(0.03,0.10) | 0.283(0.09,0.68) | Z=8.679 | <0.001 | |||||
单核比 | 0.89(0.58,0.95) | 0.94(0.89,0.97) | 0.73(0.32,0.91) | Z=-8.619 | <0.001 | |||||
血液指标 | ||||||||||
癌胚抗原(ng/ml) | 1.83(0.97,3.63) | 1.10(0.73,1.98) | 2.09(1.21,14.52) | Z=5.361 | <0.001 | |||||
癌抗原125(u/ml) | 74.00(43.70,134.90) | 79.75(46.28,133.70) | 71.50(43.35,129.75) | Z=0.016 | 0.531 | |||||
白细胞计数(×109/L) | 8.20±4.08 | 6.17±1.87 | 9.87±4.62 | t=8.229 | <0.001 | |||||
中性粒细胞计数(×109/L) | 6.25±3.86 | 4.26±1.60 | 7.87±4.39 | t=8.580 | <0.001 | |||||
中性比 | 0.73±0.11 | 0.68±0.11 | 0.78±0.10 | t=6.839 | <0.001 | |||||
淋巴细胞计数(×109/L) | 1.45±3.68 | 1.67±5.32 | 1.26±1.23 | t=-0.849 | 0.397 | |||||
淋巴比 | 0.16±0.09 | 0.19±0.09 | 0.14±0.08 | t=-4.625 | <0.001 | |||||
单核细胞计数(×109/L) | 0.70±0.77 | 0.59±0.27 | 0.78±1.01 | t==2.063 | 0.041 | |||||
单核比 | 0.08±0.03 | 0.09±0.03 | 0.07±0.02 | t=-7.030 | <0.001 | |||||
血红蛋白(g/L) | 124.59±19.36 | 124.81±18.23 | 124.42±20.32 | t=-0.152 | 0.879 | |||||
血小板计数(×109/L) | 285.24±119.75 | 328.58±104.88 | 249.75±119.85 | t=-5.258 | <0.001 | |||||
总蛋白(g/L) | 65.28±8.18 | 66.48±7.98 | 64.30±8.24 | t=-2.031 | 0.043 | |||||
谷丙转氨酶(U/L) | 31.21±31.77 | 31.82±28.40 | 30.72±34.39 | t=-0.261 | 0.794 | |||||
谷草转氨酶(U/L) | 31.43±26.15 | 30.90±19.73 | 31.87±30.53 | t=0.278 | 0.781 | |||||
肌酸激酶(U/L) | 58.72±44.11 | 58.21±41.31 | 59.18±46.74 | t=0.132 | 0.895 | |||||
肌酸激酶同工酶(U/L) | 12.92±13.31 | 10.88±8.30 | 14.72±16.37 | t=1.801 | 0.074 | |||||
凝血酶原时间(s) | 13.20±1.47 | 13.25±1.15 | 13.15±1.69 | t=-0.528 | 0.598 | |||||
INR | 1.11±0.67 | 1.17±0.97 | 1.06±0.13 | t=-1.182 | 0.239 | |||||
γ-干扰素释放试验 | χ2=99.872 | <0.001 | ||||||||
阳性 | 121(51.9) | 93(87.7) | 28(22.0) | |||||||
阴性 | 112(48.1) | 13(12.3) | 99(78.0) |
指标 | 外部验证组 | 内部实验组 | 统计 检验值 | P值 | ||||
---|---|---|---|---|---|---|---|---|
结核组(101例) | 非结核组(40例) | 统计检验值 | P值 | 合计(141例) | 合计(233例) | |||
胸腔积液 | ||||||||
总蛋白(g/L) | 51.78±7.74 | 47.46±7.21 | t=1.925 | 0.049 | 50.56±7.78 | 45.56±9.08 | t=-5.296 | <0.001 |
腺苷脱氨酶(U/L) | 43.74±15.67 | 11.43±20.54 | t=6.396 | <0.001 | 34.67±22.42 | 31.50±24.90 | t=-1.960 | 0.032 |
癌胚抗原(ng/ml) | 2.10(1.35,3.38) | 195.79(6.96,200) | Z=-3.130 | 0.028 | 2.86(1.43,8.67) | 1.17(0.50,3.21) | Z=-5.331 | <0.001 |
多核比 | 0.04(0.02,0.15) | 0.18(0.07,0.33) | Z=-2.495 | 0.013 | 0.07(0.02,0.23) | 0.11(0.05,0.42) | Z=2.823 | 0.005 |
单核比 | 0.96(0.85,0.98) | 0.81(0.66,0.93) | Z=2.495 | 0.013 | 0.93(0.77,0.98) | 0.89(0.58,0.95) | Z=-2.940 | 0.003 |
白细胞计数(×109/L) | 6.55±1.78 | 8.51±2.77 | t=-2.625 | 0.016 | 7.10±2.26 | 8.20±4.08 | t=2.556 | 0.062 |
中性比 | 0.77±0.08 | 0.77±0.08 | t=-2.486 | 0.016 | 0.73±0.08 | 0.73±0.11 | t=0.521 | 0.471 |
血小板计数(×109/L) | 334.80±102.82 | 300.13±123.11 | t=1.082 | 0.028 | 325.07±108.90 | 285.24±119.75 | t=-3.032 | <0.001 |
发热 | 28(27.7) | 10(40.0) | χ2=1.406 | 0.036 | 38(27.0) | 62(26.6) | χ2=0.612 | 0.434 |
盗汗 | 18(17.8) | 0(0.0) | χ2=0.886 | 0.046 | 18(12.7) | 13(5.6) | χ2=0.977 | 0.323 |
[1] | 陈伟, 李雪, 刘小秋, 等. 《全国结核病防治规划(2024—2030年)》解读. 中国防痨杂志, 2025, 47(2):130-136. doi:10.19982/j.issn.1000-6621.20240585. |
[2] | Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res, 2015, 43(7):e47. doi:10.1093/nar/gkv007. |
[3] | 李根, 陶学萍, 钟希, 等. T-SPOT.TB联合胸水CD64、S100A9、ADA检测诊断结核性胸腔积液的临床价值. 中华医院感染学杂志, 2025, 35(1):25-29. doi:10.11816/cn.ni.2025-240480. |
[4] |
Ou Y, Li D, Long X, et al. Study on the early diagnostic value of nanopore sequencing in alveolar lavage fluid smear-negative pulmonary tuberculosis. Braz J Microbiol, 2025, 56(1):365-372. doi:10.1007/s42770-024-01575-9.
pmid: 39621292 |
[5] | Fernández-Delgado M, Cernadas E, Barro S, et al. Do we need hundreds of classifiers to solve real world classification problems?. J Mach Learn Res, 2014, 15(1):3133-3181. doi:10.5555/2627435.2697065. |
[6] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 结核与肺部疾病杂志, 2024, 5(4):376-378. doi:10.19983/j.issn.2096-8493.2024022. |
[7] | 中华医学会呼吸病学分会. 恶性胸腔积液治疗的中国专家共识(2023年版). 中华结核和呼吸杂志, 2023, 46(12):1189-1203. doi:10.3760/cma.j.cn112147-20230902-00126. |
[8] | 中华医学会呼吸病学分会胸膜与纵隔疾病学组(筹). 胸腔积液诊断的中国专家共识. 中华结核和呼吸杂志, 2022, 45(11):1080-1096. doi:10.3760/cma.j.cn112147-20220511-00403. |
[9] | 刘波, 齐凤娥, 张建华, 等. T细胞酶联免疫斑点试验在结核性胸膜炎鉴别诊断中的应用价值. 实用医学杂志, 2015, 31(21):3592-3594. doi:10.3969/j.issn.1006-5725.2015.21.042. |
[10] | 郑春燕, 李海, 杨莉, 等. 酶联免疫斑点技术在快速诊断结核性胸膜炎中的应用. 广东医学, 2013, 34(16):2503-2506. doi:10.3969/j.issn.1001-9448.2013.16.028. |
[11] | 罗红辉, 刘育良, 罗忆群. T-SPOT.TB联合胸水ADA在结核性胸膜炎中的诊断价值. 广州医药, 2021, 52(1):109-111,129. doi:10.3969/j.issn.1000-8535.2021.01.022. |
[12] | 文玉琪, 李志惠, 任欣欣, 等. 胸腔积液结核感染T细胞斑点检测与腺苷脱氨酶对结核性胸膜炎的诊断价值. 中国医刊, 2021, 56(7):732-735. doi:10.3969/j.issn.1008-1070.2021.07.011. |
[13] | 陈德洪. 内科胸腔镜下胸膜组织Xpert MTB/RIF对诊断结核性胸膜炎的价值. 广州:广州医科大学, 2023. |
[14] | 吴一秀. 不同指标联合检测对结核性胸膜炎的诊断价值的分析. 湛江:广东医科大学, 2023. |
[15] | Feller-Kopman D, Light R. Pleural Disease. N Engl J Med, 2018, 378(8):740-751. doi:10.1056/NEJMra1403503. |
[16] | 李芳, 张坚, 郝雪琦, 等. 胸腔积液中IL-27和IFN-γ检测对结核性胸膜炎的诊断价值. 吉林大学学报(医学版), 2019, 45(2):353-358. doi:10.13481/j.1671-587x.20190224. |
[17] | Kim NY, Jang B, Gu KM, et al. Differential Diagnosis of Pleural Effusion Using Machine Learning. Ann Am Thorac Soc, 2024, 21(2):211-217. doi:10.1513/AnnalsATS.202305-410OC. |
[18] | 欧阳佩珩, 胡志德, 张蕾. 新型结核性胸腔积液诊断标志物研究进展. 中国感染与化疗杂志, 2024, 24(3):371-376. doi:10.16718/j.1009-7708.2024.03.020. |
[19] |
Dhooria S, Singh N, Aggarwal AN, et al. A randomized trial comparing the diagnostic yield of rigid and semirigid thoracoscopy in undiagnosed pleural effusions. Respir Care, 2014, 59(5):756-764. doi:10.4187/respcare.02738.
pmid: 24106326 |
[20] | 张娟, 李海芬, 李小曼, 等. 糖尿病足溃疡复发风险预测模型的构建:基于Logistic回归和支持向量机及BP神经网络模型. 中国全科医学, 2023, 26(32):4013-4019. doi:10.12114/j.issn.1007-9572.2023.0175. |
[21] | Aggarwal AN, Agarwal R, Dhooria S, et al. Unstimulated Pleural Fluid Interferon Gamma for Diagnosis of Tuberculous Pleural Effusion: a Systematic Review and Meta-analysis. J Clin Microbiol, 2021, 59(5):e02112-20. doi:10.1128/jcm.02112-20. |
[22] | Ai L, Li J, Ye T, et al. Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion. Dis Markers, 2022, 2022:5653033. doi:10.1155/2022/5653033. |
[23] | 李锐成, 郜赵伟, 董轲, 等. 胸腔积液与血清中的癌胚抗原及其比值对结核性与肺癌性胸腔积液的诊断价值. 南方医科大学学报, 2019, 39(2):175-180. doi 10.12122/j.issn.1673-4254.2019.02.08. |
[24] |
Neves DD, Dias RM, Cunha AJ. Predictive model for the diagnosis of tuberculous pleural effusion. Braz J Infect Dis, 2007, 11(1): 83-88. doi:10.1590/s1413-86702007000100019.
pmid: 17625733 |
[25] | Ruan SY, Chuang YC, Wang JY, et al. Revisiting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area. Thorax, 2012, 67(9):822-827. doi:10.1136/thoraxjnl-2011-201363. |
[26] | Adam SP, Alexandropoulos S-AN, Pardalos PM, et al. No Free Lunch Theorem: A Review. Berlin: Approximation and Optimization: Algorithms, Complexity and Applications, 2019: 57-82. doi:10.1007/978-3-030-12767-15. |
[27] | Li F, Zhu C, Zhang Y, et al. Granzyme A as biomarker for diagnosis in tuberculous pleural effusion. JCI Insight, 2024, 9(23): e185307. doi:10.1172/jci.insight.185307. |
[28] | Zhou X, Chen Y, Gui W, et al. Enhanced differential evolution algorithm for feature selection in tuberculous pleural effusion clinical characteristics analysis. Artif Intell Med, 2024, 153:102886. doi:10.1016/j.artmed.2024.102886. |
[1] | Zhang Yun, Li Kun, Liang Qingtao, Liu Zichen, Duan Hongfei, Li Xuelian, Guo Ru, Che Nanying, Yang Xinting. The diagnostic value of cell-free Mycobacterium tuberculosis DNA test on pleural effusion in early diagnosis of tuberculous pleurisy [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 835-843. |
[2] | GAO Li, PANG Xue-wen, WAN Ying, YANG Guang-wei, LI Dan, ZHANG Wen-qian, CHEN Sheng-yu. A survey on TB screening among four high-risk groups in general medical institutions in Tianjin City [J]. Chinese Journal of Antituberculosis, 2022, 44(4): 397-402. |
[3] | DONG Jing, JIA Hong-yan, SUN Qi, LI Zi-hui, WEI Rong-rong, DU Bo-ping, XING Ai-ying, PAN Li-ping, ZHANG Zong-de. Identification of approriate reference genes for the detection of miRNA in tuberculosis and malignant pleural effusion [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 261-267. |
[4] | LIU Lin. Clinical analysis of 35 pregnant tuberculous pleurisy patients [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 731-736. |
[5] | ZHU Jian-kun, MENG Qian, JIN Feng. Exploration of the expression level of lipoxin A4 and its influence mechanism in process of tuberculous pleural fibrosis [J]. Chinese Journal of Antituberculosis, 2020, 42(5): 489-492. |
[6] | Su-hua MENG. Assessment of GeneXpert MTB/RIF test for diagnosis of tuberculous pleurisy [J]. Chinese Journal of Antituberculosis, 2019, 41(9): 1005-1008. |
[7] | Yi-min SUN,Zhen-qing WANG,Jia JIA,Hua-ping GU. Application value of thinprep cytologic test in the diagnosis of pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2019, 41(8): 882-886. |
[8] | Di WU,You-fei LIN,Xiao-hong CHEN,Jian-shan SHEN,Xiao-you CHEN. Study on the diagnostic value of IL-27 and ADA alone and in combination in the tuberculous pleurisy [J]. Chinese Journal of Antituberculosis, 2019, 41(12): 1246-1251. |
[9] | Hui SUN,Hong-lan XU,Xiao-ling. LIU. Application of self-made pleural cannula dressing in the nursing care of tuberculous pleurisy [J]. Chinese Journal of Antituberculosis, 2018, 40(6): 649-651. |
[10] | Gui-rong WANG,Shu-qi WANG,Guang-lu JIANG,Mai-ling HUANG,Xin-ting YANG,Xiao-you CHEN,Hai-rong HUANG. Diagnostic value of combined detection of sputum and pleural effusion with different techniques in tuberculous pleurisy [J]. Chinese Journal of Antituberculosis, 2018, 40(4): 365-371. |
[11] | Hao-ran LIU,Ya-li ZHANG,Wei-cong REN,Ling-juan ZHAO,Chuan-you LI,Wei WANG,Meng-qiu GAO. Differential expression and diagnostic value of three cytokines in pleural effusion between pulmonary tuberculosis and lung cancer [J]. Chinese Journal of Antituberculosis, 2018, 40(10): 1046-1050. |
[12] | Ling CHEN,Li-hong LU,Jun-hong SUN. Clinical efficacy of urokinase combined with ozone sequential irrigation in the treatment of tuberculous encapsulated pleural effusion [J]. Chinese Journal of Antituberculosis, 2018, 40(10): 1095-1098. |
[13] | Lu-yan LIAO,Ming-wei ZHAO,Guo-feng. YANG. The diagnosis value of simultaneous amplification and testing for tuberculous pleural effusion [J]. Chinese Journal of Antituberculosis, 2018, 40(1): 84-86. |
[14] | Wan-li KANG,Yang LIU,Shen-jie TANG,Su-hua. ZHENG. Study on the association of different sites of tuberculous lesion in inpatients with tuberculosis from Tongzhou District, Beijing [J]. Chinese Journal of Antituberculosis, 2018, 40(1): 94-97. |
[15] | WU Jing-qiu,FANG Hong-xia,WEI Ming,XU Xin-xin,YUE Zhi-guo,LIU Yu-qin,HOU Yan-jie.. The diagnostic value of Mycobacterium tuberculosis T cell enzyme-linked immunospot tuberculous test (T-SPOT.TB) combined with adenosine deaminase (ADA) in patients with pleural tuberculosis [J]. Chinese Journal of Antituberculosis, 2017, 39(10): 1088-1092. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||